Exodus Point Capital Management, LP Trevena Inc Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.57 - $1.29 $14,135 - $31,992	-24,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.11 - $1.7 $14,874 - $22,780	13,400 Added 117.54%	24,800 $31,000
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $580,900 - $895,223	-397,877 Reduced 97.21%	11,400 $19,000
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $287,741 - $476,318	162,566 Added 65.89%	409,277 $733,000
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $497,685 - $761,715	233,655 Added 1789.64%	246,711 $528,000
Q3 2020 Nov 16, 2020	BUY	$1.53 - $3.13 $19,975 - $40,865	13,056 New	13,056 $39,000
Q1 2020 May 15, 2020	SELL	$0.56 - $0.97 $6,832 - $11,834	-12,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.62 - $1.06 $7,564 - $12,932	12,200 New	12,200 $10,000
Q2 2019 Aug 14, 2019	SELL	$0.94 - $1.6 $27,448 - $46,720	-29,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.51 - $1.88 $14,892 - $54,896	29,200 New	29,200 $46,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.